University of
Zurich, Switzerland
NCT Number: NCT02044237
Online study for patients with trichotillomania. 4 main hypothesis.
1. Alexithymia and Trichotillomania correlated and regression analyses find association between them 2. we will be able to find patient who have never been treated before. Those will suffer to the same amount as previously treated patients 3. Decoupling will be more helpful than progressive muscle relaxation 4. different constructs of emotion regulation will show different trait and state characteristics in patients with trichotillomania
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Zurich, Switzerland
Randomized controlled trial with about 100 participants.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 7 months
Time frame: 7 months
Time frame: 7 months
University of Zurich
Other
Decoupling as Internet Based Intervention: an Randomized Controlled Study to Treat Trichotillomania
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05003401
Anxiety Disorders, Disruptive, Impulse Control, and Conduct Disorders
Baltimore, Maryland, United States
View Trial DetailsNCT04241120
Anxiety Disorders, Disruptive, Impulse Control, and Conduct Disorders
Saint Louis Park, Minnesota, United States
View Trial DetailsNCT01875445
Anxiety Disorders, Disruptive, Impulse Control, and Conduct Disorders
Chicago, Illinois, United States
View Trial DetailsNCT00775229
Anxiety Disorders, Disruptive, Impulse Control, and Conduct Disorders
Chicago, Illinois, United States
View Trial Details